Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-06-09FDA Approved: STIOLTO RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for STIOLTO RESPIMAT (tiotropium bromide and olodaterol) from Boehringer Ingelheim Pharmaceutica…
-
FDA approval · 2016-06-09FDA Approved: SPIRIVA RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Spiriva Respimat (tiotropium bromide inhalation spray) filed by Boehringer Ingelheim Pharmac…
-
FDA approval · 2016-05-20FDA Approved: ALBUTEROL SULFATE HFA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Teva's Albuterol Sulfate HFA inhalation product.
-
FDA approval · 2016-05-12FDA Approved: DULERA — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for DULERA (mometasone furoate and formoterol fumarate dihydrate) submitted by Organon LLC.
-
FDA approval · 2016-05-11FDA Approved: PROAIR DIGIHALER — Supplemental Application (Teva Respiratory, LLC)
The FDA approved Teva Respiratory's supplemental application for PROAIR DIGIHALER (albuterol sulfate), authorizing the supplemental action r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-04-29FDA Approved: ATROVENT HFA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approves a supplemental application for ATROVENT HFA (ipratropium bromide) from Boehringer Ingelheim Pharmaceuticals, Inc. The approval …
-
FDA approval · 2016-04-29FDA Approved: SPIRIVA HANDIHALER — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Spiriva HandiHaler (tiotropium bromide) from Boehringer Ingelheim Pharmaceuticals, expanding…
-
FDA approval · 2016-04-29FDA Approved: ADVAIR DISKUS — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Advair Diskus (fluticasone propionate and salmeterol) from GlaxoSmithKline LLC.
-
FDA approval · 2016-04-28FDA Approved: PROAIR DIGIHALER — Supplemental Application (Teva Respiratory, LLC)
The FDA approved a supplemental application for PROAIR DIGIHALER (albuterol sulfate) from Teva Respiratory, LLC.
-
FDA approval · 2016-04-25FDA Approved: BEVESPI AEROSPHERE — Original Application (AstraZeneca Pharmaceuticals LP)
FDA approved Bevespi Aerosphere, a fixed-dose inhalation combination of glycopyrrolate and formoterol fumarate, under its original applicati…
-
FDA approval · 2016-04-15FDA Approved: COMBIVENT RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Combivent Respimat (ipratropium bromide and albuterol) by Boehringer Ingelheim Pharmaceutica…
-
FDA approval · 2016-03-24FDA Approved: IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for Ipratropium Bromide and Albuterol Sulfate from Cipla USA Inc., indicating approval of a suppleme…
-
FDA approval · 2016-03-24FDA Approved: TUDORZA PRESSAIR — Supplemental Application (Covis Pharma US, Inc)
The FDA approved a supplemental application for Tudorza Pressair (aclidinium bromide) submitted by Covis Pharma US, Inc.
-
FDA approval · 2016-03-24FDA Approved: LEVALBUTEROL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for levalbuterol, confirming approval of the generic product under an ANDA and enabling continu…
-
FDA approval · 2016-03-22FDA Approved: LEVALBUTEROL — Original Application (Mylan Pharmaceuticals Inc.)
FDA approves Mylan's original ANDA for levalbuterol hydrochloride, a generic inhaled bronchodilator indicated for reversible obstructive air…
-
FDA approval · 2016-03-18FDA Approved: STIOLTO RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approves a supplemental application for STIOLTO RESPIMAT, a fixed-dose inhaled combination of tiotropium and olodaterol, submitted by Bo…
-
FDA approval · 2016-03-16FDA Approved: TUDORZA PRESSAIR — Supplemental Application (Covis Pharma US, Inc)
The FDA approved a supplemental application for TUDORZA PRESSAIR (aclidinium bromide) submitted by Covis Pharma US, Inc.
-
FDA approval · 2016-03-03FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for albuterol sulfate from Sandoz Inc, updating the product labeling.
-
FDA approval · 2016-02-24FDA Approved: UMECLIDINIUM AND VILANTEROL ELLIPTA — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories for umeclidinium bromide and vilanterol trifenatate in the Ellipta inhaler.…
-
FDA approval · 2016-02-24FDA Approved: INCRUSE ELLIPTA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Incruse Ellipta (umeclidinium) from GlaxoSmithKline LLC. The action represents a supplemental ap…
-
FDA approval · 2016-01-22FDA Approved: XOPENEX HFA — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for XOPENEX HFA (levalbuterol tartrate).
-
FDA approval · 2016-01-15FDA Approved: SPIRIVA RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approves a supplemental application for Spiriva Respimat (tiotropium bromide inhalation spray) from Boehringer Ingelheim Pharmaceuticals…
-
FDA approval · 2016-01-10FDA Approved: ACETYLCYSTEINE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Acetylcysteine from Fresenius Kabi USA, LLC, under an ANDA.
-
FDA approval · 2015-12-11FDA Approved: PROAIR DIGIHALER — Supplemental Application (Teva Respiratory, LLC)
FDA approved a supplemental application for PROAIR DIGIHALER (albuterol sulfate) from Teva Respiratory, LLC, adding the DigiHALER device var…
-
FDA approval · 2015-12-10FDA Approved: SPIRIVA HANDIHALER — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for Spiriva HandiHalER (tiotropium bromide) from Boehringer Ingelheim Pharmaceuticals, expanding the…